opentrade on 
↗
↗event5 outcomes
When will the FDA approve Compass Pathways' COMP360 Psilocybin?
·Science and Technology·ends Jan 8, 2028vol cum
$15.5k
vol 24h
$59
outcomes
5
ends
Jan 8, 2028
outcomesclick to inspect →
marketselected outcome
Before 2028
rank #1
United States
94¢
· 0.0pp
24h change
vol cum
$1.1k
vol 24h
$0
spread
0.06
ends
Jan 8, 2028
If the FDA approves COMP360 Psilocybin for Treatment-Resistant Depression for marketing before Jan 1, 2028, then the market resolves to Yes.
timeline
opened · Mar 24, 2026opencloses · Jan 8, 2028
Before 2028 · prices over time
−24h
now
volume · by outcomehover a column to inspect
no volume history
similar markets
suggested by pdatakalshiWhen will Compass Pathways submit a NDA for COMP360 psilocybin?
before December72¢▲ 1.0ppbefore October26¢· 0.0ppbefore April 202789¢· 0.0pp
+3 others
$43 24h · 6 markets
polymarketFDA approves Retatrutide this year?
yes3¢▲ 0.6pp
$19 24h · 1 market
Will AOH1996 be FDA approved before 2040?
yes40¢· 0.0pp
M0 24h · 1 market
kalshiWill the FDA approve any psychedelic substance for medical use this year?
yes28¢▼ 1.0pp
$1.2k 24h · 1 market
polymarketFDA approves Daraxonrasib this year?
yes77¢▲ 3.5pp
$60 24h · 1 market
The FDA will approve an AI developed cure before the end of the decade (<2030) for a previously incurable major illness.
yes26¢· 0.0pp
M0 24h · 1 market